Abstract The evaluation of the premenopausal ovarian mass with transvaginal ultrasound and color Doppler is reviewed.
luteum and particularly the resorbing hemorrhagic corpus luteum can be extremely complex in appearance and can be easily mistaken as a neoplasm ( Fig. 1a and b) . Women with prior pelvic surgery or inflammatory processes can have remarkable fluid filled adhesions and loculations which should not be mistaken for neoplasm (Fig. 2) . Color Doppler as an adjunct to transvaginal gray scale-imaging can be a useful tool in improving diagnostic accuracy but misuse of arbitrary velocimetry cut-offs can also lead to unnecessary surgeries [4] . Similarly, false positive elevations of CA-125, which are particularly common in the premenopause, may lead us to suspect ovarian carcinoma.
Three diagnostic goals have been previously described for evaluation of the ovary (1) Identify hemorrhagic corpus luteum, functional cysts, hydrosalpinges, and peritoneal adhesive disease, and avoid operative interventions for them if possible. (2) Differentiate benign from malignant disease of the ovary and Fallopian tube. (3) Discriminate gastrointestinal and uterine pathology from ovarian or Fallopian tube processes. Our lab has long relied on a multi-parameter approach of the evaluation of the suspect adnexal mass. This includes age, history, reported findings of bimanual examination, transvaginal ultrasound, transabdominal ultrasound if indicated, and various tumor markers as clinically indicated. As will be outlined CT scans and MRI may be required.
To achieve the goals noted above, the clinician must have a clear understanding of the epidemiology of ovarian neoplasm both benign and malignant as the premenopausal women ages. Using the data of Koonings et al.: At ageat 20-29 and 6.3% at 40-49. The risk for frank malignancy is 4% at 20-29 and 35% at 40-49 [5] . This last percentile may seen inflated, but it must be remembered that the denominator does not include women with endometriomas, adhesive disease and functional cysts.
Several assumptions can be made that most practitioners will be comfortable with. In women aged 20-29, a cystic mass, either simple or complex is most likely a functional cyst, a hemorrhagic corpus luteum, a pelvic inflammatory process (population-dependent), an endometrioma, a cystic teratoma, or a cyst-adenoma. A small percentage of these patients will have borderline or frank malignancy. If a frankly malignant tumor is present it is more likely to be a malignant germ cell tumor or granulosa cell rather than epithelial. By age 40-49 the differential is similar except the cyst-adenomas start occurring more frequently. More importantly, the percentage of these neoplasms which are malignant neoplasms increases. If a frank ovarian malignancy is present after age 40 it is epithelial 90% of the time.
After 15 years of exhaustive study it is clear that color Doppler velocimetry as an isolated test, reveals diagnostic overlap between benign and malignant masses. Neither a PI≤1.0 or an RI≤0.4 are specific enough to differentiate a benign from malignant mass. Using a pulsatility index of≤ 1.0, Fleischer et al. in 1993 , clearly demonstrated that although their was a clear tendency for malignant ovarian neoplasms to have low resistance vessels, there was diagnostic overlap [6] . This author in fact was an early advocate of the multi-parameter approach to the suspect adnexal mass. Tekay and Jouipilla in 1994 were able to demonstrate an RI≤0.4 in 30% of benign premenopausal ovarian masses [7] . Other authors have advocated using a time averaged maximum velocity of 12.5 cm/s or greater for identifying ovarian malignancy [8] . Initial enthusiasm for color Doppler energy or power Doppler has been tempered by issues with motion artifact. Several recent logistic regression analyses have found that 95% of ovarian malignancies display two common regression analyses two common features. These two features are solid elements and central vasculature flow within these elements [9, 10] (Figs. 3 and 4a and b) . Typically these vessels display very unusual architecture.
Caution must be used in using color Doppler for routine screening. Although color Doppler typically will show a ring of flow around a corpus luteum, if taken at a more oblique angle these vessels can be seen to be quite complex and branching in appearance ( Fig. 5a and b) . Retracting clot within a corpus luteum can also be mistaken for a papillary excrescence. Partial or complete resolution with the next meses is reassuring.
The combination of color Doppler and pattern recognition is the foundation on which are lab and particularly our ovarian cancer screening program stand. In our experience endometriomas and cystic teratomas can be specifically identified with 90% accuracy [11] . Endometriomas typically are filled with uniform low level echoes on transvaginal imaging (Fig. 6 ). Some areas of echogenic speckling can be noted. These masses may be unilocular or multilocular. Doppler flow is confined to the cysts walls or septa between the locules. If central branching vascular flow is noted, a granulosa cell tumor must be considered (Fig. 7 ). An acute hemorrhagic corpus luteum may look very similar to an endometrioma [12] . Usually we will rescan in 6-8 weeks at the start of the cycle to check for resolution. Hemorrhagic corpus lutea will either be resolved or retracting clot noted. Cystic teratomas can be highly complex and are variable in appearance. They usually contain sebaceous material, hair, and cartilage [13] (Fig. 8) . Posterior shadowing is frequently noted and color Doppler is usually seen only at the periphery of the mass. Central flow may be seen if there are immature neural elements or struma-ovarri. Cystadenomas may be unilocular or multilocular. They typically have smooth walls (Fig. 9) .
A variant of the cystadenoma, the cyst-adenofibroma is a great masquerader for malignancy. The solid elements may be highly bizarre in appearance. Color Doppler will usually reveals no central vascularity with the solid elements (Fig. 10) . If multiple excrescences are noted, a borderline tumor becomes more likely. Color Doppler will not show flow into these excrescences about 30% of the time.
CA-125 should only be used in the pre-menopause as an adjunct test in a women with a suspect adnexal mass. The work of Jacob et al. suggest that CA-125 is approximately 30% sensitive with a 1% false positive rate for Stage I [14] . The 10-15% false positive rate in premenopausal women makes the test inappropriate for screening in the premenopause. In a premenopausal women with a known adnexal mass many authorities recommend CA-125 testing. Elevations can be seen with endometriosis, pelvic inflammatory disease, leiomyomas, cystic teratomas, pleural infections, and the menstrual cycle. It is an extremely nonspecific marker. If a mucinous tumor is suspect a CA 19-9 marker is commercially available. In young women with a suspect germ cell tumor HCG and AFP levels are appropriate. Many other markers are available which are beyond the scope of this review. The role of laser enhanced mass spectroscopy, proteomics testing, is controversial [15] .
MRI with gadolinium contrast should be considered to confirm pedunculated and interliagamentous leiomyomas [16] . MRI is also useful in identifying fat within cystic teratomas and blood or endometriotic fluid within ovariam masses. Computerized tomographic imaging with contrast is extremely useful for the evaluation of suspect gastrointestinal pathology, abcesses, lymph node status, and locating the ureters as well as ureteral pathology.
The role of ultrasound in screening for ovarian cancer remains controversial. Studies with primarily low-risk women have found that women will be detected at Stage I more frequently if they undergo surveillance with ultrasound [17, 18] . Excluding borderline tumors the sensitivity of annual ultrasound in low-risk women may approximate 40-50%. In expert hands approximately 10-25 surgeries will be performed for each malignancy identified. This number may be even higher if simple cystic masses are not followed expectantly [19] . For high-risk women ultrasound and in particular women with BRCA mutations, ultrasound is poorly sensitive in identifying early stage ovarian cancer [20, 21] . There is no evidence that the addition of 3D Doppler investigation of normal size ovaries improves sensitivity. There are preliminary papers that have evaluated the role of 3D Doppler examination of suspect masses [22] [23] [24] .
In summary it is critical for the clinician to recognize that in the reproductive age group many masses are physiologic or residuals of adhesive disease. History is critical in avoiding operating on women for residuas of pelvic inflammatory disease or post-operative adhesions. (Myomectomies and transplants are two prime examples) Patience will frequently prevent unnecessary surgery. Most adnexal pathology in the reproductive age group can be identified with pattern recognition. If solid elements or ascites are noted think about the possibility of malignancy. Color Doppler may improve accuracy in predicting malignancy. Color Doppler velocimetry measurements may be taken, but it is the pattern of central flow within solid elements which is most predictive. Serum markers should be chosen as clinically indicated. Routine screening with CA-125 in the premenopausal women is not indicated. CT scan and MRI are two powerful tools that should be used when the differential diagnosis is cloudy. Fig. 10 This complex cyst with two areas of excrescence was found to be a adeno-fibroma at laparoscopy. Color Doppler doesn't display flow within the excrescences. The differential diagnosis includes borderline malignancy. In our unpublished experience about 70% of cystic teratomas will reveal flow in the excrescences or solid elements of the tumor
